Chronic graft versus host disease and skin

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 5, 2003, Pages 512-517

  Fimiani, M ^a   De Aloe, G ^a   Cuccia, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALOPECIA; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DRY SKIN; EDITORIAL; ERYTHEMA; FOLLICULITIS; GRAFT VERSUS HOST REACTION; GRAM POSITIVE BACTERIUM; HERPES ZOSTER; HUMAN; INFECTION SENSITIVITY; LICHENOID; LYMPHOCYTOPOIESIS; MUCOSA INFLAMMATION; NAIL DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PIGMENT DISORDER; PRIORITY JOURNAL; RASH; SCLERODERMA; SKIN BIOPSY; SKIN CANCER; SKIN MANIFESTATION; STEM CELL TRANSPLANTATION; SWEAT GLAND DISEASE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VARICELLA ZOSTER VIRUS;

CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPERPIGMENTATION; LICHEN PLANUS; MALE; PROGNOSIS; RISK ASSESSMENT; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 0141539580     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00780.x     Document Type: Editorial

References (13)

1. Mauduit G, Claudy A. Cutaneous expression of graft-vs.-host disease in man. Semin Dermatol 1988; 7: 149-155.
2. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100: 941-947.
3. Horn TD. Effector cells in cutaneous graft-versus-host disease. Who? What? Where? How? Br J Dermatol 1999; 141: 778-779.
4. Happle R, Effendy I. Coexisting linear and disseminated drug eruption: a clinical clue to the understanding of the genetic basis of drug eruptions. Eur J Dermatol 2001; 11: 89.
5. Ameen M, Russel-Jones R. Macroscopic and microscopic mucinosis in chronic sclerodermoid graft-versus-host disease. Br J Dermatol 2000; 142: 529-532.
6. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant 1990; 5: 69-82.
7. Aractingi S, Carosella ED, Gluckman E. Manifestations cutanées de la réaction du greffon contre l'hote. Ann Dermatol Venereol 1998; 125: 620-627.
8. Andrews ML, Robertson I, Weedon D. Cutaneous manifestations of chronic graft-versus-host disease. Australas J Dermatol 1997; 38: 53-62.
9. Lacour JP, Sirvent N, Monpoux F et al. Dermatomal chronic cutaneous graft-versus-host disease at the site of prior herpes zoster. Br J Dermatol 1999; 141: 587-589.
10. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196-1201.
11. Flowers ME, Parker PM, Johnston LJ et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002; 100: 415-419.
12. Itin PH, Lautenschlager S, Orth B et al. Skin manifestations of graft-versus-host reaction following bone marrow transplantation. Schweiz Med Wochenschr 1996; 126: 339-347.
13. Dall'Amico R, Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002; 6: 296-304.